Prothena Corporation PLC (NASDAQ:PRTA)

61.19
BATS BZX Real-Time Price
As of 10:45am ET
 -0.54 / -0.87%
Today’s Change
21.06
Today|||52-Week Range
74.32
+23.87%
Year-to-Date
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
Sep 29 / Zacks.com - Paid Partner Content
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
Sep 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close61.73
Today’s open63.25
Day’s range60.97 - 63.25
Volume8,117
Average volume (3 months)567,250
Market cap$2.8B
Data as of 10:45am ET, 10/04/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-329.23%
Earnings growth (next 5 years)-6.20%
Revenue growth (last year)+23,414.30%
P/E ratioNM
Price/Sales11.94
Price/Book6.07

Competitors

----
----
----
ZLABZai Lab Ltd+1.25+3.65%
Data as of 10:44am ET, 10/04/2022

Financials

Next reporting dateNovember 8, 2022
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$200.6M
Annual profit (last year)$67.0M
Net profit margin33.39%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts